首页> 外文期刊>Journal of Medicinal Chemistry >Pharmacophore binding motifs for nicotinamide adenine dinucleotide analogues across multiple protein families: A detailed contact-based analysis of the interaction between proteins and NAD(P) cofactors
【24h】

Pharmacophore binding motifs for nicotinamide adenine dinucleotide analogues across multiple protein families: A detailed contact-based analysis of the interaction between proteins and NAD(P) cofactors

机译:跨多个蛋白质家族的烟酰胺腺嘌呤二核苷酸类似物的药理学结合基序:基于接触的蛋白质和NAD(P)辅因子相互作用的详细分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We have analyzed the protein-binding pharmacophore of NAD and its close analogues in all protein-ligand structures available in the RCSB database as of February 2012; this analysis has then been used to assess the novelty of structures emerging after that date. We show that proteins have evolved diverse pharmacophore motifs for binding the adenine moiety, fewer, but still diverse, motifs for nicotinamide, and a very limited set of motifs for binding the pyrophosphate linker. Our exhaustive analysis includes a pharmacophore contact analysis for over 1900 protein-ligand structures containing NAD analogues; we have benchmarked this set of contacts against nearly 27 000 protein-ligand structures to demonstrate that the diversity of interactions seen with NAD is very similar to that seen for all other ligands. Hence, variation in binding motifs for NAD is not distinct from that observed for other ligands and they show significant variation across protein families.
机译:我们已经分析了截至2012年2月RCSB数据库中所有蛋白质-配体结构中NAD的蛋白质结合药效团及其紧密类似物;该分析随后被用于评估该日期之后出现的结构的新颖性。我们显示蛋白质已经进化出多种用于结合腺嘌呤部分的药效基序,更少但仍是多种多样的烟酰胺基序,以及结合焦磷酸盐接头的非常有限的基序集。我们的详尽分析包括对1900多种含有NAD类似物的蛋白质-配体结构的药效团接触分析;我们将这组接触针对近27000种蛋白质-配体结构进行了基准测试,以证明NAD相互作用的多样性与所有其他配体的相互作用非常相似。因此,NAD结合基序的变化与其他配体所观察到的没有区别,它们在蛋白质家族中显示出显着变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号